CSIMarket Company Name, Ticker, Customers, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Aura Biosciences Inc   (AURA)
Other Ticker:  
 

Aura Biosciences Inc 's Tangible Leverage Ratio

AURA's quarterly Tangible Leverage Ratio and Total Liabilities, Tangible Equity growth




AURA Tangible Leverage Ratio (Mar 31 2023)
I. Quarter		 (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter		 (Jun 30 2022)
II. Quarter		 (Mar 31 2022)
I. Quarter
Y / Y Tangible Equity Change 27.76 % 28.41 % - - -
Y / Y Total Liabilities Change 382.78 % 896.91 % 393.9 % - -
Tangible Leverage Ratio MRQ 0.14 0.14 0.24 0.05 0.04
Overall Ranking # 322 # 229 # 621 # 0 # 0
Seq. Tangible Equity Change -7.84 % 69.99 % -10.87 % -8.5 % -7.37 %
Seq. Total Liabilities Change -9.14 % 0.92 % 373.74 % 11.13 % 87.62 %

New: More AURA's historic Tangible Leverage Ratio results >>


Comment on AURA Tangible Leverage Ratio in the first quarter 2023
Due to repayements of liabilities of -9.14% Aura Biosciences Inc improved Tangible Leverage Ratio in first quarter 2023 to 0.14, above the Aura Biosciences Inc 's average Tangible Leverage Ratio.

Within Biotechnology & Pharmaceuticals industry in the first quarter 2023, 42 other companies have achieved lower Tangible Leverage Ratio than Aura Biosciences Inc in the I Quarter 2023. While Tangible Leverage Ratio total ranking has deteriorated compared to the forth quarter 2022 from 229 to 322.

Explain Tangible Leverage Ratio?
What is AURA Market Share?
What are AURA´s Total Liabilities?
Tangible Leverage Ratio first quarter 2023 Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 43
Healthcare Sector # 183
Overall Market # 322


Tangible Leverage Ratio Statistics
High Average Low
0.24 0.11 0.02
(Sep 30 2022)  




Financial Statements
Aura Biosciences Inc 's Tangible Equity $ 180 Millions Visit AURA's Balance sheet
Aura Biosciences Inc 's Total Liabilities $ 26 Millions Visit AURA's Balance sheet
Source of AURA's Sales Visit AURA's Sales by Geography


Cumulative Aura Biosciences Inc 's Tangible Leverage Ratio

AURA's Tangible Leverage Ratio for the trailling 12 Months

AURA Tangible Leverage Ratio

 (Mar 31 2023)
I. Quarter		 (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter		 (Jun 30 2022)
II. Quarter		 (Mar 31 2022)
I. Quarter
Y / Y Tangible Equity TTM Growth 27.76 % 28.41 % - - -
Y / Y Total Liabilities TTM Growth 382.78 % 896.91 % 393.9 % - -
Tangible Leverage Ratio TTM 0.14 0.12 0.08 0.07 0.09
Total Ranking TTM # 2 # 2 # 186 # 1540 # 1487
Seq. Tangible Equity TTM Growth -7.84 % 69.99 % -10.87 % -8.5 % -7.37 %
Seq. Total Liabilities TTM Growth -9.14 % 0.92 % 373.74 % 11.13 % 87.62 %

AURA Company Profile >> Back to AURA Financial Strength Comparisons >> See AURA Balance Sheets

TTM Tangible Leverage Ratio Comment
On the trailing twelve months basis Despite of the repayements of liabilities of -9.14% in the trailling twelve months ending in I Quarter 2023, Tangible Leverage Ratio improved to 0.14, above Aura Biosciences Inc 's average Tangible Leverage Ratio.
Tangible Leverage Ratio is the average cumulative value over the last four quarters.

Among companies in the Biotechnology & Pharmaceuticals industry 42, during the past 12 months, other companies have achieved lower Tangible Leverage Ratio than Aura Biosciences Inc . While total ranking remained unchanged compared to previous 12 month period at no. 2.

Explain Tangible Leverage Ratio?
What is AURA Market Share?
What are AURA´s Total Liabilities?

TTM Tangible Leverage Ratio Company Ranking
Within: No.
Within the Biotechnology & Pharmaceuticals Industry # 43
Healthcare Sector # 183
Within the Market # 322


TTM Tangible Leverage Ratio Statistics
High Average Low
0.24 0.11 0.02
(Sep 30 2022)  




Companies with similar Tangible Leverage Ratio in the quarter ending Mar 31 2023, within Biotechnology & Pharmaceuticals Industry Tangible Leverage RatioMar 31 2023 MRQ Total LiabilitiesMar 31 2023 MRQ Tangible Equity
Gritstone Bio Inc   0.39 $ 54.499  Millions$ 140.878  Millions
Biomerica Inc   0.38 $ 2.224  Millions$ 5.831  Millions
Vericel Corporation  0.38 $ 71.118  Millions$ 186.634  Millions
Black Diamond Therapeutics Inc   0.38 $ 37.392  Millions$ 98.190  Millions
Vicarious Surgical Inc   0.38 $ 33.362  Millions$ 87.728  Millions
Inogen Inc   0.37 $ 92.013  Millions$ 248.410  Millions
Sangamo Therapeutics Inc   0.37 $ 104.957  Millions$ 284.055  Millions
Vir Biotechnology Inc   0.36 $ 695.179  Millions$ 1,921.242  Millions
Predictive Oncology Inc   0.36 $ 6.507  Millions$ 18.281  Millions
Lifeloc Technologies Inc   0.34 $ 2.074  Millions$ 6.032  Millions
Seagen Inc   0.32 $ 713.228  Millions$ 2,216.659  Millions
Milestone Scientific Inc   0.31 $ 2.791  Millions$ 9.037  Millions
Fusion Pharmaceuticals Inc   0.30 $ 61.080  Millions$ 200.833  Millions
Scholar Rock Holding Corp  0.30 $ 68.400  Millions$ 228.653  Millions
Adverum Biotechnologies Inc   0.29 $ 46.472  Millions$ 157.757  Millions
Scientific Industries Inc   0.29 $ 3.295  Millions$ 11.320  Millions
Moderna Inc   0.28 $ 5,262.000  Millions$ 18,863.000  Millions
Cognition Therapeutics inc   0.28 $ 9.880  Millions$ 35.783  Millions
Omega Therapeutics Inc   0.27 $ 33.315  Millions$ 123.000  Millions
Monte Rosa Therapeutics Inc   0.27 $ 65.302  Millions$ 243.726  Millions
Allogene Therapeutics Inc   0.26 $ 154.609  Millions$ 592.262  Millions
Allovir Inc   0.26 $ 50.512  Millions$ 193.532  Millions
Passage Bio inc   0.25 $ 42.892  Millions$ 170.351  Millions
Solid Biosciences Inc   0.25 $ 45.801  Millions$ 183.787  Millions
Caribou Biosciences Inc   0.25 $ 69.190  Millions$ 278.272  Millions
Hillevax Inc   0.24 $ 57.900  Millions$ 243.061  Millions
Cue Health Inc   0.24 $ 112.698  Millions$ 476.089  Millions
Exelixis Inc   0.24 $ 588.223  Millions$ 2,491.452  Millions
Lakeland Industries Inc   0.24 $ 24.956  Millions$ 105.725  Millions
Cytek Biosciences Inc   0.24 $ 89.574  Millions$ 379.653  Millions

Date modified: 2023-05-14T12:48:18+00:00



Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071